Ironwood Pharmaceuticals, Inc. (IRWD)
4.26
-0.03
(-0.70%)
USD |
NASDAQ |
Sep 04, 16:00
4.26
0.00 (0.00%)
After-Hours: 20:00
Ironwood Pharmaceuticals SG&A Expense (TTM) : 64.55M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 64.55M |
| March 31, 2026 | 70.03M |
| December 31, 2025 | 82.26M |
| September 30, 2025 | 96.29M |
| June 30, 2025 | 110.50M |
| March 31, 2025 | 130.67M |
| December 31, 2024 | 144.01M |
| September 30, 2024 | 149.35M |
| June 30, 2024 | 149.28M |
| March 31, 2024 | 164.80M |
| December 31, 2023 | 158.31M |
| September 30, 2023 | 148.04M |
| June 30, 2023 | 140.61M |
| March 31, 2023 | 118.25M |
| December 31, 2022 | 115.99M |
| September 30, 2022 | 116.29M |
| June 30, 2022 | 115.41M |
| March 31, 2022 | 112.34M |
| December 31, 2021 | 111.13M |
| September 30, 2021 | 116.43M |
| June 30, 2021 | 123.61M |
| March 31, 2021 | 131.20M |
| December 31, 2020 | 140.00M |
| September 30, 2020 | 145.21M |
| June 30, 2020 | 151.20M |
| Date | Value |
|---|---|
| March 31, 2020 | 159.80M |
| December 31, 2019 | 172.45M |
| September 30, 2019 | 183.68M |
| June 30, 2019 | 193.30M |
| March 31, 2019 | 209.83M |
| December 31, 2018 | 222.65M |
| September 30, 2018 | 230.18M |
| June 30, 2018 | 241.42M |
| March 31, 2018 | 239.44M |
| December 31, 2017 | 233.12M |
| September 30, 2017 | 230.38M |
| June 30, 2017 | 213.59M |
| March 31, 2017 | 192.72M |
| December 31, 2016 | 173.28M |
| September 30, 2016 | 149.58M |
| June 30, 2016 | 135.03M |
| March 31, 2016 | 131.07M |
| December 31, 2015 | 125.25M |
| September 30, 2015 | 124.32M |
| June 30, 2015 | 122.41M |
| March 31, 2015 | 118.76M |
| December 31, 2014 | 118.33M |
| September 30, 2014 | 116.48M |
| June 30, 2014 | 118.21M |
| March 31, 2014 | 119.78M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Rigel Pharmaceuticals, Inc. | 122.22M |
| AbbVie, Inc. | 14.67B |
| Marker Therapeutics, Inc. | 4.244M |
| Theriva Biologics, Inc. | 6.919M |
| Fortress Biotech, Inc. | 68.84M |